SEATTLE, Jan. 30, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and treatment of ...
SEATTLE, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical-stage biopharmaceutical company dedicated to the prevention and ...
Enhance your stock picks with dividend metrics like per-share dividends, yield, frequency, payout ratios, and more.
After hours: 7:37:47 p.m. EST ...
Seattle Magazine on MSN4d
Matters of the HeartThe keys to heart health are relatively straightforward: Maintain a healthy weight. Reduce alcohol consumption. Quit smoking.
After hours: 7 February at 19:37:47 GMT-5 ...
Dyne Therapeutics Inc.-5.60% $1.56B ...
Sanofi S.A. Part Cert 0.02% €8.03M ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback